1.Effects of cyclosporin A treatment on the pathogenesis of avian leukosis virus subgroup J infection in broiler chickens with Marek's disease virus exposure.
Yongbaek KIM ; Thomas P BROWN ; Mary J PANTIN-JACKWOOD
Journal of Veterinary Science 2003;4(3):245-255
In this study, we investigated the effects of T-cell suppression on the pathogenesis of subgroup J avian leukosis virus (ALV-J). Chickens were treated with cyclosporin A (CSP) 50 mg/Kg body weight or a corresponding volume of olive oil per every three days after hatching until the end of experiment. Some of the chickens from each treatment group were infected with an isolate of ALV-J, ADOL-7501, at 2 weeks of age. The effects of viral infection were compared to uninfected birds in same treatment group. Intramuscular injection of CSP induced significant T-cell specific immunosuppression determined by decreased cutaneous basophilic hypersensitivity response and decreased lymphocyte mitogenic activity using concanavalin A. Most of the chickens examined had Marek's disease virus infection prior to 3 weeks of age. The percentage of antibody-positive birds and antibody titers were similar in infected chickens between both treatment groups. The ratio of viremic chickens was significantly higher in CSP treated group than that of the Oil treated group. Microscopically, one CSP treated chicken had a nephroblastoma at 10 weeks post infection. At 7 and 10 weeks post-infection, more chickens had myeloid cell infiltrations in multiple organs including heart, liver and occasionally lung. Expression of ALV-J viral antigen determined by immunohistochemical staining was significantly higher in CSP treated chickens than Oil treated chickens at 10 weeks post-infection. This study indicated that chemically-induced T-cell suppression may enhance pathogenicity of the AVL-J virus in broilers.
Animals
;
Antibodies, Viral/blood
;
Avian Leukosis/*immunology/virology
;
Avian leukosis virus/genetics/*immunology
;
Body Weight
;
*Chickens
;
Cyclosporine/*pharmacology
;
Dermatitis, Contact/immunology/virology
;
Flow Cytometry
;
Immunocompromised Host
;
Immunohistochemistry/veterinary
;
Immunophenotyping
;
Immunosuppressive Agents/*pharmacology
;
Lymphocyte Activation/immunology
;
Marek Disease/*immunology/virology
;
RNA, Viral/chemistry/genetics
;
Reverse Transcriptase Polymerase Chain Reaction/veterinary
;
T-Lymphocytes/*immunology/virology
;
Viremia/veterinary
2.Alphavirus replicon-vectored plasmid DNA-based vaccine elicits protective immunity against classical swine fever virus.
Na LI ; Jian-Jun ZHAO ; He-Ping ZHAO ; Yuan SUN ; Qing-Hu ZHU ; Guang-Zhi TONG ; Hua-Ji QIU
Chinese Journal of Biotechnology 2007;23(3):434-439
We have shown previously that a Semliki Forest virus (SFV) replicon vectored DNA vaccine (pSFV1CS-E2) expressing the E2 glycoprotein of classical swine fever virus (CSFV) conferred full protection for pigs immunized three times with 600 microg of the vaccine. This study aims to evaluate the efficacy of the DNA vaccine with lower dosage and fewer inoculations. Pigs were immunized twice with 100 microg pSFV1CS-E2 (n = 5) or control plasmid pSFV1CS (n = 3), respectively. Pigs immunized with pSFV1CS-E2 developed high titers of specific neutralizing antibodies against CSFV after the booster, and the antibody titers increased rapidly upon challenge. The immunized animals showed no clinical symptoms except short-term fever and low-level viremia, whereas the control pigs immunized with the control plasmid produced no detectable antibody before challenge and showed obvious clinical signs following challenge, and 2 pigs died on 10 or 11 days post-challenge. All control animals developed extended viremia as detected by nested RT-PCR and real-time RT-PCR. Severe pathologic lesions typical of CSFV infection were observed at necropsy. We conclude that the alphavirus replicon-vectored DNA-based vaccine can be potential marker vaccine against CSFV.
Animals
;
Antibodies, Neutralizing
;
blood
;
immunology
;
Antibodies, Viral
;
blood
;
immunology
;
Body Temperature
;
immunology
;
Classical Swine Fever
;
blood
;
immunology
;
prevention & control
;
Classical swine fever virus
;
genetics
;
immunology
;
Genetic Vectors
;
genetics
;
Immunization
;
Plasmids
;
genetics
;
Replicon
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Semliki forest virus
;
genetics
;
Swine
;
virology
;
Time Factors
;
Vaccines, DNA
;
administration & dosage
;
genetics
;
immunology
;
Viral Envelope Proteins
;
genetics
;
immunology
;
Viremia
;
genetics
;
immunology
3.The effects of cyclophosphamide treatment on the pathogenesis of subgroup J avian leukosis virus (ALV-J) infection in broiler chickens with Marek's disease virus exposure.
Yongbaek KIM ; Thomas P BROWN ; Mary J PANTIN-JACKWOOD
Journal of Veterinary Science 2004;5(1):49-58
Studies were performed to determine the effects of Bcell suppression on the pathogenesis of Subgroup J avian leukosis virus (ALV-J) in broiler chickens. Neonatal chickens were treated with cyclophosphamide (CY) or PBS, and then infected with ALV-J (ADOL-7501) at 2 weeks of age. CY treatment induced B cell specific immunosuppression throughout the experiment confirmed by decreased bursal weight, intact lymphocyte mitogenetic activity stimulated by Con A and increased relative subpopulation of CD3-positive cells as measured by flow cytometry. Chickens in this experiment had Mareks disease virus exposure prior to three weeks of age as determined by the presence of lymphocytic infiltration and antibody. Virus neutralizing antibody against ALV-J was first observed at 6 weeks post-infection in some of the infected chickens in the PBS group. As expected, none of the chickens from the CY group and uninfected chickens developed virus-neutralizing antibody. The viremic status was measured by real time RT-PCR using SYBR green I dye. The percentage of viremic chickens was significantly higher, and more chickens had high titered viremia, in the CY treated group. No neoplastic foci consistent with ALVJ infection were observed in any of the experimental chickens. The frequency and intensity of viral antigen expression determined by immunohistochemistry was significantly higher in tissues from CY treated birds than those of PBS treated chickens at 3 weeks post-infection. This study showed that B cell specific immunosuppression with CY treatment in chickens resulted in increase in viremia and viral antigen load in tissues.
Animals
;
Avian Leukosis/*immunology/virology
;
Avian leukosis virus/genetics/*immunology
;
Body Weight/physiology
;
Bursa of Fabricius/immunology
;
*Chickens
;
Concanavalin A/immunology
;
Cyclophosphamide/*pharmacology
;
Flow Cytometry/veterinary
;
Immunocompromised Host
;
Immunohistochemistry/veterinary
;
Immunophenotyping/veterinary
;
Immunosuppressive Agents/*pharmacology
;
Lymphocyte Activation/drug effects/immunology
;
Organic Chemicals/chemistry
;
Poultry Diseases/immunology/*virology
;
RNA, Viral/chemistry/genetics
;
Random Allocation
;
Reverse Transcriptase Polymerase Chain Reaction/veterinary
;
Spleen/immunology/virology
;
Statistics, Nonparametric
;
Viremia/veterinary
4.Genetic analysis of ORF5 of recent Korean porcine reproductive and respiratory syndrome viruses (PRRSVs) in viremic sera collected from MLV-vaccinating or non-vaccinating farms.
Hye Kwon KIM ; Jeong Sun YANG ; Hyoung Joon MOON ; Seong Jun PARK ; Yuzi LUO ; Chul Seung LEE ; Dae Sub SONG ; Bo Kyu KANG ; Soo Kyung ANN ; Chan Hyuk JUN ; Bong Kyun PARK
Journal of Veterinary Science 2009;10(2):121-130
The 23 open reading frame (ORF) 5 sequences of Korean type II porcine reproductive and respiratory syndrome virus (PRRSV) were collected from viremic sera from the (modified live vaccine) MLV-vaccinating and non-vaccinating farms from 2007 to 2008. The samples were phylogenetically analyzed with previous ORF5 sequences, including type I Korean PRRSV, and previously reported or collected sequences from 1997 to 2008. A MN184-like subgroup of type II Korean PRRSV was newly identified in the viremic sera collected from 2007 to 2008. And of the type I PRRSVs, one subgroup had 87.2~88.9% similarity with the Lelystad virus, showing a close relationship with the 27~2003 strain of Spain. The maximum parsimony tree of type II PRRSV from 1997 to 2008 showed that they had evolved to four lineages, subgroups 1, 2, 3 and 4. Most of the recently collected type II PRRSVs belonged to subgroup 4 (48%). The region of three B-cell epitopes and two T-cell epitopes of ORF5 amino acids sequences was considerably different from the MLV in subgroups 3 and 4. In conclusion, the existence of type I PRRSV, which was genetically different from Lelystad virus (Prototype of type I PRRSV), and heterologous type II PRRSVs of viremic pigs detected even in the MLV-vaccinating farms indicated the need for new vaccine approaches for the control of PRRSV in Korea.
Animals
;
Epitopes, B-Lymphocyte/immunology
;
Epitopes, T-Lymphocyte/immunology
;
Evolution, Molecular
;
Korea
;
*Open Reading Frames
;
Phylogeny
;
Pilot Projects
;
Porcine Reproductive and Respiratory Syndrome/blood/genetics/immunology/*virology
;
Porcine respiratory and reproductive syndrome virus/*genetics/immunology
;
RNA, Viral/chemistry/genetics
;
Reverse Transcriptase Polymerase Chain Reaction/veterinary
;
Swine
;
Viral Vaccines/immunology/standards
;
Viremia/genetics/immunology/virology
5.HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
Yan-Meng FENG ; Yan-Min WAN ; Lian-Xin LIU ; Chao QIU ; Peng-Fei MA ; Hong PENG ; Yu-Hua RUAN ; Li-Feng HAN ; Kun-Xue HONG ; Hui XING ; Yi-Ming SHAO
Biomedical and Environmental Sciences 2010;23(5):391-401
OBJECTIVEConflicting data have been generated from previous studies to determine which kind of relationship exists between HIV-1 specific CD8 Tcell responses and HIV-1 viral load or CD4 count over the course of infection. In this study, 153 HIV-1 infected LTNPs were enrolled to investigate the role of HIV-1 specific CD8 T-cell responses in chronic HIV-1 infection among HIV-1 infected former blood donors.
METHODSThe patients were stratified into three groups according to CD4 count: CD4≥500 cells/μL; 350 cells/μL≤CD4<500 cells/μL; CD4<350 cells/μL. PBMCs were isolated from the patients' anticoagulated blood samples. IL-2 and IFN-γ secretions of CD 8 T cells against 17 HIV-1 consensus B full peptide pools were analyzed by using ICS assay.
RESULTSAn overall inverse correlation were observed between CD4 count and plasma viral load. Although no significant difference was observed during the comparisons of frequency/breadth of HIV-1 specific CD8 T cell responses, CD4 count stratification analysis showed that different correlation pattern existed in three strata: as for patients whose CD4 counts were less than 350 cells/μL, no significant correlations were identified between frequency/breadth of HIV-1 specific CD8 T cell responses and CD4 count/viral load; as for patients whose CD4 counts ranged from 350 cells/μL to 500 cells/μL, significant correlation was only observed between the response breadth of IL-2+IFN-γ+ CD8 T cells and CD4 count; however, as for patients whose CD4 counts were more than 500 cells/μL, direct correlations were identified between IL-2+IFN-γ+/IL-2+/IFN-γ+ CD8 T cells and viral load or CD4 count.
CONCLUSIONSUniversal consistent inverse correlation was only indentified between CD4 count and viral load. The relationship between HIV-1 specific CD8 T cell responses and CD4 count/viral load varied in different CD4 strata, which showed that better preserved CD4 T cells were correlated with better CD8 T cell functions.
Adult ; Antigens, Viral ; immunology ; Blood Donors ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes ; cytology ; CD8-Positive T-Lymphocytes ; cytology ; immunology ; China ; epidemiology ; Chronic Disease ; Cohort Studies ; Disease Progression ; Female ; Flow Cytometry ; HIV Infections ; blood ; epidemiology ; immunology ; virology ; HIV-1 ; genetics ; immunology ; Humans ; Interferon-gamma ; immunology ; Interleukin-2 ; immunology ; Lymphocyte Activation ; immunology ; Male ; Polymerase Chain Reaction ; Viral Load ; Viremia